Printer Friendly

Articles from The Fly (March 26, 2018)

1-117 out of 117 article(s)
Title Author Type Words
37 attorneys general send letter to Facebook 'demanding answers'. 129
Acorda Therapeutics submits MAA to the EMA for INBRIJA. 131
Active trading in GE as shares fall to fresh 52-week lows. 154
Akorn and former CFO agree to settle to reporting, accounting control violations. 145
Alnylam's lumasiran gets priority medicine access. 114
Amag Pharmaceuticals submits NDA to FDA for bremelanotide. 256
Amdocs collaborates with Microsoft to enable ONAP on Microsoft Azure. 126
Amdocs collaborates with Microsoft to enable ONAP on Microsoft Azure. 128
Analyst sees path through cloud for trillion dollar valuation of Microsoft. 333
Appian, VASS extend strategic alliance across UK, Latin America. 145
Apple CEO calls for 'well-crafted' regulation on data privacy, Bloomberg reports. 107
Apricus Biosciences announces scheduling of Vitaros end-of-review FDA meeting. 166
Armo BioSciences completes first interim analysis in Phase 3 SEQUOIA study. 255
Biohaven says two Phase 3 clinical trials for migraine met efficacy endpoints. 324
Biohaven slides as migraine drug studies compared to competitors'. 554
BioScrip CEO says addressing weaknesses in internal controls. 144
Boeing delivers first 787-10 Dreamliner to Singapore Airlines. 197
Boeing HorizonX invests in nanosatellite communications startup Myriota. 103
Bristol-Myers receives positive CHMP opinion recommending approval of Opdivo. 101
Broadcom announces Singapore court hearing to approve scheme of redomiciliation. 109
Cantor reiterates Overweight on Aimmune ahead of AnaptysBio data. 137
Carpenter Technology to invest $100M in soft magnetics capabilites, equipment. 107
Cboe: U.S. regulators should not stand in the way of bitcoin ETFs, Reuters says. 103
Citi to add full suite of banking tools to mobile app for all users, WSJ reports. 121
City of London responds to The China Fund's annual meeting postponement. 301
CNIT receives $1.2M cloud-based ad terminal order for Zhangzhou, Longyan. 171
Common Cause asks DOJ probe whether Cambridge Analytica broke U.S. election law. 149
comScore Chair of the Board, Susan Riley, to step down. 139
Cumberland says data demonstrates 85% eradication of ulcer causing bacteria. 302
Dana increases cash consideration for GKN Driveline by $140M, increases buyback. 181
DarioHealth gets FDA clearance for iPhone 7, 8 and iPhone X Smart Glucose Meter. 112
Dentsply Sirona to acquire OraMetrix, terms not disclosed. 191
Deutsche sees no 'easy fix' for Ford, but likes near-term risk/reward. 118
Document Security wins appeal, federal circuit reverses PTAB ruling. 190
Dollar General to expand distribution operations at Tejon Ranch. 144
Euro$ interest rate futures are lower. 122
Facebook drops after FTC confirms probe of data practices. 355
Facebook to expand local news feature beyond U.S. 260
Finish Line to be acquired by JD Sports Fashion for $13.50 per share. 204
Flex Pharma: FLX-787 reduced cramp frequency in MS patients in Phase 2 trial. 231
Former AIG CEO's bailout challenge rejected by top U.S. court, Reuters reports. 104
FTC confirms it has open non-public probe into Facebook's practices. 136
Futures sharply higher as trade war worries ease. 127
FX Action: AUD-JPY has rebounded sharply. 136
FX Update: The dollar and yen traded softer. 202
GE investors voice concerns over leftovers of GE Capital, WSJ reports. 102
Gebr. Knauf offers to acquire USG for $42 per share. 363
Genentech says Phase III IMpower150 study met co-primary endpoint. 122
Goldman's stock-based pay ratio still much higher than rivals, Reuters reports. 101
Gulf Island Fabrication received termination letter from customer for two MPSVs. 106
Health-insurance premiums likely to rise before November elections, WSJ reports. 117
Heavy trading in Facebook options and implied volatility reaches 52-week highs. 136
iKang enters into definitive merger agreement for going private transaction. 866
International Paper remains willing to engage with Smurfit Kappa after rejection. 294
JAKKS Pacific announces update on special committee process. 192
Kanen nominates four candidates to board of Aqua Metals. 173
Kansas City Southern to pay $25M annually due to foreign earnings tax, WSJ says. 112
Kinross Gold announces end of SEC investigation of West Africa operations. 315
Kinross Gold settles FCPA violations with SEC for $950,000. 143
Legacy Reserves rises 10% after announcing plans to become C-Corp. 353
Lowe's CEO says 'confident' it's the right time to transition leadership. 123
Lowe's jumps after CEO Robert Niblock announces retirement plans. 312
Micron price target raised to $75 from $55 at Argus. 110
Microsoft has path to $1T market cap, says Morgan Stanley. 150
MiMedx says Phase 2b plantar fasciitis study statistically significant. 243
Navios Acquisition to sell one VLCC to Navios Maritime Midstream for $44.5M. 129
Navios Maritime Midstream announces fleet renewal and distribution. 186
On The Fly: Top five analyst downgrades. 209
On The Fly: Top five analyst upgrades. 163
On The Fly: Top stock stories at midday. 410
Onconova presents 'promising' clinical safety data from Phase 2 expansion study. 388
Palatin: Amag Pharmaceuticals submits bremelanotide NDA to FDA. 108
Paychex sees FY18 total revenue growth 7%, consensus $3.36B. 138
Protagonist Therapeutics to discontinue Phase 2b PROPEL study. 185
RADA Electronic establishes U.S. subsidiary RADA Technologies. 101
Raytheon to begin work on $600M U.S. Army contract. 153
Republicans urge Trump to allow F-35 fighter jet sale to Taiwan, Reuters reports. 143
Roche issues challenge to Bristol, Merck cancer drugs with Tecentriq cocktail. 349
Roku jumps after analyst says company now has stronger brand, bigger moat. 302
Seven Stars Cloud Group launches utility token for crude oil index. 158
Sibanye-Stillwater upgraded to Buy from Neutral at Goldman Sachs. 102
Sigma Labs signs cooperative agreement with NIST. 171
Smurfit Kappa rejects revised takeover proposal from International Paper. 213
Snap in focus after model Chrissy Teigen says she's stopped using Snap. 300
SoftBank probing who was behind campaign seeking to oust top execs, WSJ says. 110
Sunrun expands national partneship with GRID Alternatives. 152
Syntel joins Google Cloud partner program. 114
Technical Take: iShares Select Dividend ETF and S&P 500 impact. 179
Technical Take: S&P 500 off lows of the day at mid-session. 106
Technical Take: SPDR S&P 500 ETF Trust implied futures end of day pricing. 145
TechnipFMC awarded iEPCITM contract by LLOG Exploration. 118
Tenet board reaches agreement with Glenview Capital Management. 218
Tenet in focus after agreement with Glenview Capital Management. 554
Tenet reaches agreement with Glenview Capital management. 223
Tesla car shipments in Norway get shut down for safety reasons, electrek reports. 108
Toshiba expects China clearance for chip sale 'within days', FT reports. 111
Travelport shareholder Elliott Management urges company to explore sale. 181
Treasury 2-year auction outlook:. 317
Treasury 2-year auction preview: the $30 B sale could show lukewarm stats. 282
Treasury Action: 2 down, 5 to go, in terms of this week's auctions. 168
Treasury Action: short yields backed up. 101
Treasury Curve Action: flattening has prevailed. 108
Treasury Market Outlook: Treasury yields are several basis points higher. 261
Treasury's $30 B 2-year auction was ok, though the results were mixed. 129
Trump plan to battle opioids favors one company, Alkermes, STAT says. 115
U.S. Chicago Fed National Activity index surged to 0.88 in February. 126
U.S. corporate bond update: issuance is climbing. 133
U.S. Dallas Fed manufacturing index fell back 15.8 points to 21.4 in March. 149
U.S. equities have snapped back. 194
U.S., S. Korea revise trade deal, put quotas on Korean steel, Reuters says. 120
USG board unanimously rejects unsolicited proposal from Knauf. 143
USG present value could be above $50 in 'best case scenario,' says Stifel. 107
Viacom announces strategic partnership with Trevor Noah's Day Zero Productions. 104
Wells Fargo says FTC announcement expected, buy Facebook shares. 106
White House says Russia needs to change behavior for 'better relationship'. 164
William Blair sees Biohaven safety as 'strong differentiator' versus Allergan. 225
Zynerba says preclinical data shows effect of ZYN002 in reduction of replase. 323

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters